Drugs target to POLR2A

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
TAS-106Small moleculehead and neck malignant neoplasiaDNA-directed RNA polymerase II subunit RPB1 inhibitor2.0TerminatedClinicalTrials
TAS-106Small moleculecancerDNA-directed RNA polymerase II subunit RPB1 inhibitor1.0CompletedClinicalTrials